COMBINATION CHEMOTHERAPY OF CISPLATIN AND 5-FLUOROURACIL FOR ADVANCED COLORECTAL ADENOCARCINOMA

被引：0
|
作者：
PETRELLI, NJ
MADEJEWICZ, S
RUSTUM, Y
HERRERA, L
CREAVEN, PJ
PLAGER, J
SOLOMAN, J
MITTELMAN, A
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT EXPTL THERAPEUT,BUFFALO,NY 14263
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT CLIN PHARMACOL & THERAPEUT,BUFFALO,NY 14263
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1989年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：57 / 60
页数：4
相关论文
共 50 条
  • [41] CISPLATIN AND 5-FLUOROURACIL IN ADVANCED CANCER OF THE PENIS
    SHAMMAS, FV
    OUS, S
    FOSSA, SD
    [J]. JOURNAL OF UROLOGY, 1992, 147 (03): : 630 - 632
  • [42] COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE PLUS 5-FLUOROURACIL FOR TREATMENT OF UNRESECTABLE PANCREATIC ADENOCARCINOMA
    CHLEBOWSKI, R
    GOTA, C
    GLASS, A
    WEINER, J
    BATEMAN, JR
    [J]. CLINICAL RESEARCH, 1978, 26 (03): : A432 - A432
  • [43] COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE PLUS 5-FLUOROURACIL FOR THE TREATMENT OF UNRESECTABLE PANCREATIC ADENOCARCINOMA
    CHLEBOWSKI, R
    GOTA, C
    GLASS, A
    WEINER, J
    BATEMAN, JR
    [J]. CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2119 - 2121
  • [44] Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma
    Kim, S.
    Paget-Bailly, S.
    Messager, M.
    Nguyen, T.
    Mathieu, P.
    Lamfichekh, N.
    Fein, F.
    Fratte, S.
    Cleau, D.
    Lakkis, Z.
    Jary, M.
    Sakek, N.
    Jacquin, M.
    Foubert, A.
    Bonnetain, F.
    Mariette, C.
    Fiteni, F.
    Borg, C.
    [J]. EJSO, 2017, 43 (01): : 218 - 225
  • [45] Paclitaxel, 5-fluorouracil and cisplatin (PFC) combination in patients with localized or advanced adenocarcinoma of the stomach or gastroesophageal junction: A preliminary report
    Arnbrosini, G.
    Soini, B.
    Frisinghelli, M.
    Brugnara, S.
    Caldara, A.
    Caffo, O.
    Ferro, A.
    Murgia, V
    Valduga, F.
    Galligioni, E.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 51 - 52
  • [46] Cisplatin monotherapy with concurrent radiotherapy versus combination of cisplatin and 5-fluorouracil chemotherapy with concurrent radiotherapy in patients with locoregionally advanced cervical carcinoma
    Nedovic, J.
    Protrka, Z.
    Ninkovic, S.
    Mitrovic, S.
    Vojinovic, R.
    Glisic, J.
    Markovic-Filipovic, B.
    Milosevic, B.
    Peulic, M.
    Cvetkovic, A.
    [J]. JOURNAL OF BUON, 2012, 17 (04): : 740 - 745
  • [47] Docetaxol 5-Fluorouracil, Cisplatin versus Epirubicin, 5-Fluorouracil, Cisplatin for advanced gastric carcinoma: Preliminary report
    Sadighi, Sanambar
    Mohagheghi, M. A.
    Raafat, J.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 235 - 235
  • [48] Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil and cisplatin
    Azria, D
    Ychou, M
    Jacot, W
    Thezenas, S
    Lemanski, C
    Senesse, P
    Prost, P
    Delard, R
    Masson, B
    Dubois, JB
    [J]. PANCREAS, 2002, 25 (04) : 360 - 365
  • [49] Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma
    Andre, T
    Lotz, JP
    Bouleuc, C
    Azzouzi, K
    Houry, S
    Hannoun, L
    See, J
    Esteso, A
    Avenin, D
    Izrael, V
    [J]. ANNALS OF ONCOLOGY, 1996, 7 (02) : 173 - 178
  • [50] The Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine (PEFG) Regimen in Advanced Biliary Tract Adenocarcinoma
    Cereda, Stefano
    Passoni, Paolo
    Reni, Michele
    Vigano, Maria G.
    Aldrighetti, Luca
    Nicoletti, Roberto
    Villa, Eugenio
    [J]. CANCER, 2010, 116 (09) : 2208 - 2214
12345